Vela Diagnostics Sentosa SQ Thyroid Cancer Panel
Vela Diagnostics has launched the CE marked Sentosa SQ Thyroid Cancer Panel for next-generation sequencing-based variant detection and identification. The new panel is designed to simultaneously detect 105 hot spots in 10 genes associated with thyroid cancer. It exhibits a limit of detection of 5 percent variant frequency with a DNA requirement of 5 nanograms per library, and has a clinical sensitivity of 100 percent, the company said. The panel has been validated on the Sentosa NGS system, which automates sample extraction, library construction, template preparation, sequencing, analysis, and reporting.